PNC Financial Services Group’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.9K | Sell |
758
-1,627
| -68% | -$27.7K | ﹤0.01% | 3764 |
|
|
2025
Q1 | $46.6K | Buy |
2,385
+268
| +13% | +$5.23K | ﹤0.01% | 3138 |
|
|
2024
Q4 | $52.5K | Buy |
2,117
+105
| +5% | +$2.6K | ﹤0.01% | 3077 |
|
|
2024
Q3 | $49.3K | Buy |
2,012
+42
| +2% | +$1.03K | ﹤0.01% | 3099 |
|
|
2024
Q2 | $46.2K | Buy |
1,970
+198
| +11% | +$4.64K | ﹤0.01% | 3072 |
|
|
2024
Q1 | $58.5K | Buy |
1,772
+208
| +13% | +$6.87K | ﹤0.01% | 2918 |
|
|
2023
Q4 | $42.6K | Buy |
1,564
+923
| +144% | +$25.1K | ﹤0.01% | 3052 |
|
|
2023
Q3 | $15.4K | Buy |
641
+297
| +86% | +$7.14K | ﹤0.01% | 3567 |
|
|
2023
Q2 | $11K | Buy |
344
+262
| +320% | +$8.37K | ﹤0.01% | 3837 |
|
|
2023
Q1 | $2.51K | Buy |
82
+33
| +67% | +$1.01K | ﹤0.01% | 4249 |
|
|
2022
Q4 | $1.92K | Sell |
49
-16
| -25% | -$626 | ﹤0.01% | 4273 |
|
|
2022
Q3 | $4K | Buy |
65
+43
| +195% | +$2.65K | ﹤0.01% | 4005 |
|
|
2022
Q2 | $0 | Sell |
22
-5,014
| -100% | – | ﹤0.01% | 4486 |
|
|
2022
Q1 | $289K | Sell |
5,036
-7
| -0.1% | -$402 | ﹤0.01% | 2026 |
|
|
2021
Q4 | $402K | Sell |
5,043
-1,009
| -17% | -$80.4K | ﹤0.01% | 1842 |
|
|
2021
Q3 | $526K | Buy |
6,052
+240
| +4% | +$20.9K | ﹤0.01% | 1570 |
|
|
2021
Q2 | $748K | Buy |
5,812
+329
| +6% | +$42.3K | ﹤0.01% | 1362 |
|
|
2021
Q1 | $439K | Buy |
5,483
+131
| +2% | +$10.5K | ﹤0.01% | 1652 |
|
|
2020
Q4 | $436K | Buy |
5,352
+352
| +7% | +$28.7K | ﹤0.01% | 1566 |
|
|
2020
Q3 | $123K | Buy |
+5,000
| New | +$123K | ﹤0.01% | 2201 |
|